trending Market Intelligence /marketintelligence/en/news-insights/trending/u5gwev8pmpehzg0ktski8q2 content esgSubNav
In This List

Cidara appoints independent director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cidara appoints independent director

Cidara Therapeutics Inc. appointed Chrysa Mineo as an independent director.

The appointment expands the biotechnology company's board to seven directors.

From 2009 to 2015, Mineo led corporate development at Receptos Inc., which was later acquired by Celgene Corp.